Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease

Falk Müller-Riemenschneider, Kathrin Damm, Charlotte Meinhard, Angelina Bockelbrink, Christoph Vauth, Stefan N. Willich & Wolfgang Greiner
Background Coronary heart disease (CHD) is a common and potentially fatal malady with a life time prevalence of over 20%. For Germany, the mortality attributable to chronic ischemic heart disease or acute myocardial infarction is estimated at 140,000 deaths per year. An association between prognosis of CHD and lifestyle risk factors has been consistently shown. To positively influence lifestyle risk factors in patients with CHD, non-pharmaceutical secondary prevention strategies are frequently recommended and implemented. Objectives...